Question 1

What is Bicara Therapeutics's accrued expenses?

Accepted Answer

Bicara Therapeutics (BCAX) reported accrued expenses of $1.91M in Q1 2026.

Question 2

How has Bicara Therapeutics's accrued expenses changed year-over-year?

Accepted Answer

Bicara Therapeutics's accrued expenses increased by 14.1% year-over-year, from $1.68M to $1.91M.

Question 3

What is the long-term trend for Bicara Therapeutics's accrued expenses?

Accepted Answer

Over 2 years (2023 to 2025), Bicara Therapeutics's accrued expenses has grown at a -20.9% compound annual growth rate (CAGR), from $8.05M to $5.04M.

Question 4

What does accrued expenses mean?

Accepted Answer

Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Line item	March 31,2026	December 31,2025
Accrued research and development expenses	$13,516	$13,085
Accrued manufacturing expenses	12,615	—
Accrued bonus and payroll related expenses	1,913	5,041
Accrued professional fees	1,666	591
Accrued other	238	181
Total	$29,948	$18,898

Accrued Expenses at other companies

Other financials